 When a regulator hits the brakes on a drugs advancement, small businesses can buckle under the pressure. This seems to be happening with Veru NASDAQ: VERU today as the Food and Drug Administration FDA denied an emergency use authorization EUA for Verus proposed Covid-19 drug. 